お知らせ

論文がアクセプトされました。”Sumiyoshi R, Koga T, Kamisawa O, Morimoto S, Hosogaya N, Yamamoto H, Hori M, Inaba Y, Hattori Y, Hikake T, Kurokawa T, Hanaoka H, Sato S, Migita K, Ogawa N, Hashimoto M, Kawakami A. A phase II investigator-initiated, continuation trial of 5-aminolevulinic acid hydrochloride/ sodium ferrous citrate (5-ALA-HCl/ SFC) for patients with adult-onset Still’s disease (AOSD) refractory to glucocorticoids. Drug Discov Ther.”